[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kane Biotech Inc (KNE.VN)

Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 6,152
  • Shares Outstanding, K 205,057
  • Annual Sales, $ 428 K
  • Annual Income, $ -2,721 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.97
  • Price/Sales 93.14
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on 05/28/26
  • Next Earnings Date 06/04/26
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.028 +7.14%
on 06/19/26
0.035 -14.29%
on 06/08/26
unch (unch)
since 05/19/26
3-Month
0.028 +7.14%
on 06/19/26
0.040 -25.00%
on 05/08/26
unch (unch)
since 03/19/26
52-Week
0.025 +20.00%
on 11/04/25
0.060 -50.00%
on 06/30/25
-0.025 (-45.45%)
since 06/19/25

Most Recent Stories

More News
Kane Biotech Announces Grant of Stock Options

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane”...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Announces First Quarter 2026 Financial Results

WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results. ...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 26, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane”...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress

WINNIPEG, Manitoba, May 13, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announced today its participation in the World Council of Enterostomal...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Announces New Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane”...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results

WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Upcoming Meeting Dates - April 20, 2026

Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through...

SGN.VN : 0.295 (-3.28%)
TXP.TO : 0.1300 (+4.00%)
MAI.VN : 5.170 (-1.15%)
WVM.VN : 1.680 (-1.18%)
BRAG.TO : 2.39 (-4.02%)
BRM.VN : 3.080 (-0.65%)
BYRG.CN : 0.2200 (-2.22%)
CPH.TO : 16.33 (+0.93%)
GAME.VN : 1.800 (+5.88%)
RSM.VN : 0.295 (-1.67%)
ESM.TO : 0.1650 (unch)
IPT.VN : 0.325 (+7.26%)
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference

>20 year‑old venous leg ulcers show dramatic healing and pain elimination with revyve Thermoreversible revyve transforms deep tunneling wound care, delivering 90% wound volume reduction revyve...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms

WINNIPEG, Manitoba, March 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) announces that Frontiers in Antibiotics has published a peer-reviewed article...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

WINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the Company), transforming wound care with three FDA 510(k) cleared and two Health Canada approved formats, is pleased...

KNE.VN : 0.030 (unch)
KNBIF : 0.0250 (+24.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise...

See More

Key Turning Points

3rd Resistance Point 0.033
2nd Resistance Point 0.031
1st Resistance Point 0.031
Last Price 0.030
1st Support Level 0.029
2nd Support Level 0.027
3rd Support Level 0.027

See More

52-Week High 0.060
Fibonacci 61.8% 0.047
Fibonacci 50% 0.042
Fibonacci 38.2% 0.038
Last Price 0.030
52-Week Low 0.025

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.